Inventor
WILTON STEPHEN DONALD
AU43 patents
⚠️ This page may combine multiple inventors who share the name “WILTON STEPHEN DONALD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV WESTERN AUSTRALIA
27 patentsUSRE47751EDec 3, 2019
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
UNIV WESTERN AUSTRALIA41 citations99
US9994851B2Jun 12, 2018
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
UNIV WESTERN AUSTRALIA51 citations99
US9447415B2Sep 20, 2016
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
UNIV WESTERN AUSTRALIA99 citations99
US9441229B2Sep 13, 2016
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
UNIV WESTERN AUSTRALIA66 citations99
US9422555B2Aug 23, 2016
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
UNIV WESTERN AUSTRALIA68 citations99
US9249416B2Feb 2, 2016
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
UNIV WESTERN AUSTRALIA74 citations99
US9175286B2Nov 3, 2015
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
UNIV WESTERN AUSTRALIA74 citations99
US9035040B2May 19, 2015
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
UNIV WESTERN AUSTRALIA67 citations99
US9024007B2May 5, 2015
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
UNIV WESTERN AUSTRALIA90 citations99
US9018368B2Apr 28, 2015
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
UNIV WESTERN AUSTRALIA93 citations99
US7960541B2Jun 14, 2011
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
UNIV WESTERN AUSTRALIA147 citations99
US7807816B2Oct 5, 2010
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
UNIV WESTERN AUSTRALIA129 citations99
US10995337B2May 4, 2021
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
UNIV WESTERN AUSTRALIA14 citations98
US10968450B2Apr 6, 2021
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
UNIV WESTERN AUSTRALIA14 citations98
US10781451B2Sep 22, 2020
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
UNIV WESTERN AUSTRALIA32 citations98
USRE47769EDec 17, 2019
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
UNIV WESTERN AUSTRALIA31 citations98
USRE47691ENov 5, 2019
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
UNIV WESTERN AUSTRALIA23 citations98
US10421966B2Sep 24, 2019
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
UNIV WESTERN AUSTRALIA23 citations98
US10266827B2Apr 23, 2019
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
UNIV WESTERN AUSTRALIA33 citations98
US10227590B2Mar 12, 2019
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
UNIV WESTERN AUSTRALIA34 citations98
US9605262B2Mar 28, 2017
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
UNIV WESTERN AUSTRALIA36 citations98
US9228187B2Jan 5, 2016
Antisense molecules and methods for treating pathologies
UNIV WESTERN AUSTRALIA97 citations98
US9758783B2Sep 12, 2017
Antisense molecules and methods for treating pathologies
UNIV WESTERN AUSTRALIA52 citations97
US10781450B2Sep 22, 2020
Antisense molecules and methods for treating pathologies
UNIV WESTERN AUSTRALIA24 citations93
USRE48960EMar 8, 2022
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
UNIV WESTERN AUSTRALIA13 citations86
US11447776B2Sep 20, 2022
Antisense molecules and methods for treating pathologies
UNIV WESTERN AUSTRALIA0 citations62
US11459563B2Oct 4, 2022
Treatment for NEAT1 associated disease
UNIV WESTERN AUSTRALIA0 citations53
WILTON STEPHEN DONALD
9 patentsUS8524880B2Sep 3, 2013
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
WILTON STEPHEN DONALD110 citations99
US8486907B2Jul 16, 2013
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
WILTON STEPHEN DONALD108 citations99
US8476423B2Jul 2, 2013
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
WILTON STEPHEN DONALD75 citations99
US8455635B2Jun 4, 2013
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
WILTON STEPHEN DONALD75 citations99
US8455634B2Jun 4, 2013
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
WILTON STEPHEN DONALD77 citations99
US8455636B2Jun 4, 2013
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
WILTON STEPHEN DONALD118 citations99
US8450474B2May 28, 2013
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
WILTON STEPHEN DONALD75 citations99
US8232384B2Jul 31, 2012
Antisense oligonucleotides for inducing exon skipping and methods of use thereof
WILTON STEPHEN DONALD151 citations99
US8637483B2Jan 28, 2014
Antisense molecules and methods for treating pathologies
WILTON STEPHEN DONALD85 citations98
UNIV MONS
3 patentsUS10907157B2Feb 2, 2021
Agents useful in treating facioscapulohumeral muscular dystrophy
UNIV MONS15 citations89
US9988628B2Jun 5, 2018
Agents useful in treating facioscapulohumeral muscular dystrophy
UNIV MONS18 citations89
US11898143B2Feb 13, 2024
Agents useful in treating facioscapulohumeral muscular dystrophy
UNIV MONS0 citations57